TrialHaematologica2013

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

Barbara Kiesewetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.